The Biotechnology Program has also expanded its STEM outreach efforts to include a summer internship program for high school ...

A novel study has unveiled a technique that enhances stem cell therapy for neurodegenerative diseases by combining magnetic ...

Funding will enable company to expand research capacity and scale up unique genome editing technology designed to treat ...

Presented positive 4- and 12-week clinical results of ongoing type 1 diabetes study showing that hypoimmune-modified pancreatic islet cells transplan ...

plush-carpeted hospital is getting ready to welcome its first patients. Building on the Nobel-prizewinning work of stem-cell scientist Shinya Yamanaka, researchers across the country are crafting ...

"We're proud to be a Semifinalist team of XPRIZE Healthspan, a 7-year, $101 million global competition that aims to ...

Trailhead Biosystems Inc. ( a biotechnology company advancing human cell innovation, has secured $20 million in financing. Trailhead specializes in precisely differentiating induced pluripotent stem ...

These clusters appear to regulate communication between cells and their environment. Now, reporting in Nature Biotechnology, Flynn's team in the Stem Cell ... a first application of this newfound ...

This central process allows cells to grow, divide, and stay alive. It has accompanied life since its origin ... but also to improve stem cell-based embryo models for applications that require ...

Neurodegenerative diseases like Parkinson's and Alzheimer's are characterized by irreversible neuron damage and limited ...

The labs of Ryan Flynn at Boston Children’s Hospital and Konstantinos Tzelepis at the Cambridge Stem Cell Institute have found a readily druggable target on the surface of acute myeloid leukemia (AML) ...